GCP
ORMP icon

GSA Capital Partners’s Oramed Pharmaceuticals ORMP Stock Holding History

GSA Capital Partners’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-88,923
Closed -$232K – 1799
2023
Q3 		$232K Sell
88,923
-75,673
-46% -$238K 0.02% 1217
2023
Q2 		$589K Buy
+164,596
New +$528K 0.06% 643
2023
Q1 		– Sell
-46,039
Closed -$554K – 1814
2022
Q4 		$554K Buy
+46,039
New +$358K 0.07% 540
2020
Q4 		– Sell
-19,659
Closed -$51K – 1501
2020
Q3 		$51K Buy
+19,659
New +$68.5K 0.01% 1184

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $249M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return